Personalized Medicine – Products

Thermo Fisher Scientific Inc. has announced that it has completed its acquisition of Olink Holding AB, a provider of next-generation proteomics solutions.

This case study presents a scalable, automation-friendly workflow for active deparaffinization, extraction and purification of nucleic acids from FFPE samples that can transform cancer diagnostics as demand grows.

Leica Microsystems, has released version 14 of Aivia, its flagship image analysis solution. This update introduces a suite of new features and enhancements for accurate deep-learning based cell segmentation.

At ASMS 2024, SCIEX, introduces ZT Scan DIA for LC-MS/MS, the next generation in data-independent acquisition (DIA) that leverages the combination of the quadrupole dimension with the rich MS2 data attainable from the Zeno trap.

New analytical instruments and workflow capabilities improve productivity, reliability and sensitivity of discovery, translational and clinical research.

Thermo Fisher Scientific Inc. (NYSE: TMO), unveiled the Thermo Scientific™ Stellar™ mass spectrometer (MS), a new solution that combines fast throughput, high sensitivity, and ease of use.

The Tartu University Hospital, North Estonia Medical Centre, and Icosagen have joined forces to develop and introduce an innovative personalized cell therapy (CAR-T cell therapy) for patients in Estonia.

Plasma-based proteomic platform predicts clinical benefit from immune-checkpoint inhibitors in NSCLC, melanoma, and HPV-related cancers.

New workflow to provide unambiguous genetic results in a single assay, alleviating the need for time-consuming and costly follow-up tests.

Sartorius to leverage NVIDIA solutions used in live-cell imaging platforms in drug discovery and predictive design of manufacturing processes, and more.